Timothy L Madden

Timothy L Madden

UNVERIFIED PROFILE

Are you Timothy L Madden?   Register this Author

Register author
Timothy L Madden

Timothy L Madden

Publications by authors named "Timothy L Madden"

Are you Timothy L Madden?   Register this Author

12Publications

216Reads

22Profile Views

Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma.

Clin Cancer Res 2012 Feb 5;18(4):1120-8. Epub 2012 Jan 5.

Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Pathology, Experimental Therapeutics, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906678PMC
February 2012

Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity.

Mol Cancer Ther 2011 Jul 13;10(7):1300-7. Epub 2011 May 13.

Department of Investigational Cancer Therapeutics, Unit 0455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-11
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-11-0259DOI Listing
July 2011

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

Clin Cancer Res 2008 Dec;14(23):7909-16

Department of Breast Medical Oncology, Pathology, Surgical Oncology, Radiation Oncology and Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375958PMC
December 2008

The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

Cancer Res 2007 May;67(9):4210-8

Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-3629DOI Listing
May 2007

Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors.

Clin Cancer Res 2003 Jun;9(6):2066-71

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
June 2003

Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of Nerium oleander.

J Exp Ther Oncol 2002 Sep-Oct;2(5):278-85

Pharmaceutical Development Center, University of Texas M.D. Anderson Cancer Center, 8000 El Rio, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
March 2003

Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.

Cancer Chemother Pharmacol 2002 Aug 25;50(2):85-94. Epub 2002 Jun 25.

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-002-0456-0DOI Listing
August 2002